Accumulating evidence indicate that constitutive activation of NF-κB in tumor cells always contribute to chemoresistance and radioresistance, and represents an independent risk factor for recurrence after radical prostatectomy [40], [42], [43]. The gene discussed is NFKB1; the disease is neoplasm.